Regulatory bodies are promoting Risk Based (Quality) Monitoring as a best practice in clinical trials to correct data quality issues as early as possible in the trial lifecycle. Since this involves the identification of specific patterns in large datasets, artificial intelligence can support us in doing this efficiently.
- How can AI find specific patterns that humans might miss
- Interactions between AI and humans in RB(Q)M
- Real life examples in respiratory
• Strategies for sourcing components from a scattered ecosystem
• How to develop meaningful, human-centric measures
• Pitfalls and opportunities for analytical and clinical validation
• Novel solutions and digital pathways for scalable regulatory qualification
• Maximizing value: how to repurpose and extend solutions across use cases in R&D and healthcare
• Considering recent key geopolitical trends’ impact on the future of healthcare and pharma
• Investigating the cause of recurring supply chain disruptions
• Learning how to build supply chain resilience